Şirin, G. Et Al. 2015. Meaningful Reduction of Hepatocellular Carcinoma Risk In Patients with Chronic Hepatitis C Who Received Pegile Interferon Plus Ribavirin Therapy: Two tertiary Center Experience.. 23 th United European Gastroenterology Week , (Barcelona, Spain).

Şirin, G., Şentürk, Ö., Çelebi, A., Yılmaz, H., Sezikli, M., & Hülagü, S., (2015). Meaningful Reduction of Hepatocellular Carcinoma Risk In Patients with Chronic Hepatitis C Who Received Pegile Interferon Plus Ribavirin Therapy: Two tertiary Center Experience. . 23 th United European Gastroenterology Week, Barcelona, Spain

Şirin, GÖKTUĞ Et Al. "Meaningful Reduction of Hepatocellular Carcinoma Risk In Patients with Chronic Hepatitis C Who Received Pegile Interferon Plus Ribavirin Therapy: Two tertiary Center Experience.," 23 th United European Gastroenterology Week, Barcelona, Spain, 2015

Şirin, GÖKTUĞ Et Al. "Meaningful Reduction of Hepatocellular Carcinoma Risk In Patients with Chronic Hepatitis C Who Received Pegile Interferon Plus Ribavirin Therapy: Two tertiary Center Experience.." 23 th United European Gastroenterology Week , Barcelona, Spain, 2015

Şirin, G. Et Al. (2015) . "Meaningful Reduction of Hepatocellular Carcinoma Risk In Patients with Chronic Hepatitis C Who Received Pegile Interferon Plus Ribavirin Therapy: Two tertiary Center Experience.." 23 th United European Gastroenterology Week , Barcelona, Spain.

@conferencepaper{conferencepaper, author={GÖKTUĞ ŞİRİN Et Al. }, title={Meaningful Reduction of Hepatocellular Carcinoma Risk In Patients with Chronic Hepatitis C Who Received Pegile Interferon Plus Ribavirin Therapy: Two tertiary Center Experience.}, congress name={23 th United European Gastroenterology Week}, city={Barcelona}, country={Spain}, year={2015}}